Dr. Rainer Böger Joins Medical Advisory Board

Friday, April 20, 2012

Synergy WorldWide is pleased to announce that Professor Rainer H. Böger, M.D., leading expert in L-arginine research, has joined Synergy’s Medical and Scientific Advisory Board.

Dr. Böger received his medical training at Hannover Medical School in Hannover, Germany. He received his postgraduate training in Internal Medicine and Pharmacology both in Hannover and at Stanford University School of Medicine in Stanford, CA.

Dr. Böger is currently the Professor of Clinical Pharmacology and Director of the Institute of Clinical Pharmacology and Toxicology at Hamburg University Medical Center, Germany. He is also Director of the Clinical Trial Center North at Hamburg University.

Dr. Böger’s scientific work centers on the early diagnosis and prevention of cardiovascular related diseases. Dating back to the beginning of his medical career, Dr. Böger has been heavily involved in the research and treatment of cardiovascular related diseases. In 1991, while working closely with pharmaceutical drug companies to develop treatments that could combat and alleviate such diseases, he became highly interested in nitric oxide (NO) and its effects on the vascular system.

Dr. Böger has dedicated 21 years of academic research in basic science and clinical studies related to L-arginine and its influence on the body’s ability to produce NO. His major achievements are the discovery that ADMA (asymmetric dimethylarginine) is a risk marker of vascular disease and the utilization of L-arginine to prevent vascular dysfunction and disease.

Dr. Böger collaborates with renowned institutions like the Mayo Clinic and Stanford University Medical Center. He has documented his knowledge in more than 200 scientific articles, of which 130 exclusively cover the roles of ADMA and L-arginine in cardiovascular and metabolic diseases.

Dr. Böger’s extensive knowledge, expertise, and ongoing research clearly set him apart as one of the world’s leading L-arginine experts. This new partnership will further assist Synergy WorldWide in its effort to remain at the forefront of heart health.

Dr. Böger, it’s an honor you join the Synergy team.

Click here to see all the members of Synergy's Medical & Scientific Advisory Board. 

Synergy WorldWide

Some say he’s half man half fish, others say he’s more of a seventy/thirty split. Either way he’s a fishy bastard.